Literature DB >> 19936937

Spectrofluorimetric method for the determination of doxepin hydrochloride in commercial dosage forms.

Nafisur Rahman1, Sana Siddiqui, Syed Najmul Hejaz Azmi.   

Abstract

A novel spectrofluorimetric method has been developed for the determination of doxepin hydrochloride in commercial dosage forms. The method is based on the fluorescent ion pair complex formation of the drug with eosin Y in the presence of sodium acetate-acetic acid buffer solution of pH 4.52 which is extractable in dichloromethane. The extracted complex showed fluorescence intensity at lambdaem=567 nm after excitation at 464 nm. The calibration curve was linear over the working range of 0.1-0.8 microg ml(-1). Under the optimized experimental conditions, present method is validated as per International Conference on Harmonization guidelines. The limit of detection for the developed method is 2.95 ng ml(-1). The method has been successfully applied to the determination of doxepin hydrochloride in commercial dosage forms. The results are compared with the reference spectrofluorimetric method.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19936937      PMCID: PMC2799607          DOI: 10.1208/s12249-009-9341-z

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  10 in total

1.  Analysis of tricyclic antidepressants using electrogenerated chemiluminescence.

Authors:  G M Greenway; S J Dolman
Journal:  Analyst       Date:  1999-05       Impact factor: 4.616

2.  Spectrophotometric determination of some antidepressant drugs using 3-methylbenzothiazolin-2-one hydrazone.

Authors:  H D Revanasiddappa; B Manju
Journal:  Eur J Pharm Sci       Date:  1999-12       Impact factor: 4.384

3.  A simple high-performance liquid chromatography method for the quantitation of tricyclic antidepressant drugs in human plasma or serum.

Authors:  A M Nyanda; M G Nunes; A Ramesh
Journal:  J Toxicol Clin Toxicol       Date:  2000

4.  Densitometric high performance thin-layer chromatography identification and quantitative analysis of psychotropic drugs.

Authors:  Anna Maślanka; Jan Krzek
Journal:  J AOAC Int       Date:  2005 Jan-Feb       Impact factor: 1.913

5.  Simultaneous determination of psychotropic drugs in human urine by capillary electrophoresis with electrochemiluminescence detection.

Authors:  Jianguo Li; Fengjuan Zhao; Huangxian Ju
Journal:  Anal Chim Acta       Date:  2006-05-27       Impact factor: 6.558

6.  Colorimetric, ultraviolet spectrophotometric, and spectrophotofluorometric determination of doxepine and some of its metabolites in serum and in urine.

Authors:  A Devriendt; I Weemaes; F H Jansen
Journal:  Arzneimittelforschung       Date:  1973-06

7.  Extractive spectrophotometric methods for the determination of doxepin hydrochloride in pharmaceutical preparations using titanium (IV) and iron (III) thiocyanate complexes.

Authors:  Wiesława Misiuk
Journal:  Farmaco       Date:  2004-12-19

8.  Fast liquid chromatographic-mass spectrometric determination of pharmaceutical compounds.

Authors:  K Heinig; J Henion
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-09-24

9.  Optimised procedures for the reversed-phase liquid chromatographic analysis of formulations containing tricyclic antidepressants.

Authors:  M J Ruiz-Angel; S Carda-Broch; E F Simó-Alfonso; M C García-Alvarez-Coque
Journal:  J Pharm Biomed Anal       Date:  2003-04-24       Impact factor: 3.935

10.  Response surface methodology for the optimisation of flow-injection analysis with in situ solvent extraction and fluorimetric assay of tricyclic antidepressants.

Authors:  María-Isabel Acedo-Valenzuela; Teresa Galeano-Díaz; Nielene Mora-Díez; Antonio Silva-Rodríguez
Journal:  Talanta       Date:  2005-01-21       Impact factor: 6.057

  10 in total
  1 in total

1.  Determination of galantamine hydrobromide in bulk drug and pharmaceutical dosage form by spectrofluorimetry.

Authors:  Amit V Patel; Vishal J Patel; Avani V Patel; Jayant B Dave; Chhaganbhai N Patel
Journal:  J Pharm Bioallied Sci       Date:  2013-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.